SE0203479D0 - Novel drug target - Google Patents

Novel drug target

Info

Publication number
SE0203479D0
SE0203479D0 SE0203479A SE0203479A SE0203479D0 SE 0203479 D0 SE0203479 D0 SE 0203479D0 SE 0203479 A SE0203479 A SE 0203479A SE 0203479 A SE0203479 A SE 0203479A SE 0203479 D0 SE0203479 D0 SE 0203479D0
Authority
SE
Sweden
Prior art keywords
gst
treatment
cancer
relates
steroid hormone
Prior art date
Application number
SE0203479A
Other languages
English (en)
Inventor
Bengt Mannervik
Original Assignee
Bengt Mannervik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Mannervik filed Critical Bengt Mannervik
Priority to SE0203479A priority Critical patent/SE0203479D0/sv
Publication of SE0203479D0 publication Critical patent/SE0203479D0/sv
Priority to AU2003279691A priority patent/AU2003279691A1/en
Priority to US10/534,998 priority patent/US20060148020A1/en
Priority to JP2004555203A priority patent/JP2006506998A/ja
Priority to PCT/SE2003/001817 priority patent/WO2004048577A1/en
Priority to CA002506411A priority patent/CA2506411A1/en
Priority to EP03773030A priority patent/EP1567645A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE0203479A 2002-11-22 2002-11-22 Novel drug target SE0203479D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0203479A SE0203479D0 (sv) 2002-11-22 2002-11-22 Novel drug target
AU2003279691A AU2003279691A1 (en) 2002-11-22 2003-11-24 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer
US10/534,998 US20060148020A1 (en) 2002-11-22 2003-11-24 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer
JP2004555203A JP2006506998A (ja) 2002-11-22 2003-11-24 癌の治療のためのｇｓｔａ３−３およびｇｓｔａ１−１の阻害剤
PCT/SE2003/001817 WO2004048577A1 (en) 2002-11-22 2003-11-24 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer
CA002506411A CA2506411A1 (en) 2002-11-22 2003-11-24 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer
EP03773030A EP1567645A1 (en) 2002-11-22 2003-11-24 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0203479A SE0203479D0 (sv) 2002-11-22 2002-11-22 Novel drug target

Publications (1)

Publication Number Publication Date
SE0203479D0 true SE0203479D0 (sv) 2002-11-22

Family

ID=20289664

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0203479A SE0203479D0 (sv) 2002-11-22 2002-11-22 Novel drug target

Country Status (7)

Country Link
US (1) US20060148020A1 (sv)
EP (1) EP1567645A1 (sv)
JP (1) JP2006506998A (sv)
AU (1) AU2003279691A1 (sv)
CA (1) CA2506411A1 (sv)
SE (1) SE0203479D0 (sv)
WO (1) WO2004048577A1 (sv)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020601A1 (en) * 1994-01-31 1995-08-03 The University Of North Carolina At Chapel Hill Reagents binding vinculin, dynein, and glutathione s-transferase from peptide libraries
US5767147A (en) * 1995-04-21 1998-06-16 The Regents Of The University Of California Inhibition of glutathione transferase by haloenol lactones
US6063570A (en) * 1997-09-05 2000-05-16 E. I. Du Pont De Nemours And Company Soybean glutathione-S-transferase enzymes
WO2000018937A1 (en) * 1998-09-30 2000-04-06 E.I. Du Pont De Nemours And Company Maize glutathione-s-transferase enzymes

Also Published As

Publication number Publication date
AU2003279691A1 (en) 2004-06-18
CA2506411A1 (en) 2004-06-10
WO2004048577A1 (en) 2004-06-10
JP2006506998A (ja) 2006-03-02
EP1567645A1 (en) 2005-08-31
US20060148020A1 (en) 2006-07-06

Similar Documents

Publication Publication Date Title
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
MXPA05013224A (es) Piridinilcarbamatos como inhibidores de lipasa sensible a hormonas.
DE50310516D1 (de) Fredericamycin-derivate
EA200600414A1 (ru) ПРОИЗВОДНЫЕ БОРОНОВОЙ КИСЛОТЫ (ВАРИАНТЫ), ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, КОМПОЗИЦИЯ ДЛЯ ИНГИБИРОВАНИЯ АКТИВНОСТИ NF-kB И ДЕГРАДАЦИИ БЕЛКА И СПОСОБЫ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ (ВАРИАНТЫ)
BRPI0308208B8 (pt) compostos inibidores de catepsina cisteína protease e composições farmacêuticas compreendendo os mesmos
ATE443043T1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
BRPI0513565A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, métodos para inibir uma atividade de proteìna cinase, e para tratar um paciente tendo uma condição que é mediada por atividade de proteìna cinase, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
BRPI0512397A (pt) composto,produto farmacêutico, métodos para suprimir a metástase de cáncer ou o crescimento do cáncer, para prevenir ou tratar uma doença ou condição, para controlar a função placentária, para melhorar a função gonadal, para induzir ou estimular a ovulação, para promover a secreção do hormÈnio gonadotrópico ou promover a secreção do hormÈnio sexual, para suprimir a secreção do hormÈnio gonadotrópico ou suprimir a secreção do hormÈnio sexual, para infra regular hormÈnio gonadrotópico ou hormÈnio sexual, e a proteìna ot7t175 humana, e para realçar a estabilidade no sangue, uso do composto, e, agente para suprimir a secreção do hormÈnio gonadotrópico ou um agente para suprimir a secreção do hormÈnio sexual
DE60030889D1 (de) Verwendung von egfr tyrosine kinase hemmern zur behandlung von brustkrebs
EA200971053A1 (ru) Способы лечения кожных язв
ATE323474T1 (de) Farnesyl protein transferase inhibitoren zur behandlung von brustkrebs
BRPI0410979A (pt) composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia
DE602004004665D1 (en) Acetylenderivate als inhibitoren von histondeacetylase
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BR0214672A (pt) Inibidores de fosfolipase citosólica a2
DE60319083D1 (de) Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin entzug
ATE191472T1 (de) Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen
ATE263569T1 (de) Unterdrückung von inhibitoren
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
DE60309887D1 (de) Kombination von einem aromatasehemmer mit einem bisphosphonat
MX339096B (es) Compuestos inhibidores de metaloproteasa a base de feniletiniltiofeno y su uso en el tratamiento del dolor y otras enfermedades.
BR0314081A (pt) Terapia de combinação compreendendo um bisfosfonato e um inibidor de hmg-coa redutase
MXPA05013226A (es) Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas.
TR200101245T2 (tr) N-arilsulfonil-aminoasit-omega-amidler
ATE381930T1 (de) Kombinationsmedikationen mit einem selektiven cyclooxygenase-2-inhibitor